OllieDX: Investment Opportunity in AI-Enabled Neurodevelopmental Healthcare

OllieDX: Investment Opportunity in AI-Enabled Neurodevelopmental Healthcare

OllieDX is seeking investment and strategic partnerships to advance an AI-enabled healthcare platform designed to improve access to ADHD screening, assessment support and neurodevelopmental services.

Our vision is to make neurodevelopmental assessment more accessible, consistent and efficient by combining artificial intelligence, behavioural analysis and clinician-led care.

The opportunity

ADHD assessment services face growing demand, long waiting lists and pressure on clinical resources. Current pathways often involve multiple appointments, questionnaires, clinical interviews and manual interpretation of information.

OllieDX is developing technology to help healthcare professionals collect, analyse and interpret relevant assessment information while retaining clinical oversight.

Our initial focus is ADHD, with longer-term opportunities to expand into other neurodevelopmental assessment pathways, subject to clinical validation and regulatory requirements.

Our technology

OllieDX is developing a multimodal AI platform combining Continuous Performance Testing, motion tracking, eye tracking, natural language processing and structured symptom questionnaires.

The proposed platform aims to provide clinicians with structured behavioural insights, assessment summaries and information supporting further clinical evaluation.

It is designed to complement professional assessment, not replace qualified clinicians or independently diagnose ADHD.

Commercial opportunity

We are exploring a scalable healthcare technology business model serving several markets.

NHS and private healthcare providers could use OllieDX to support assessment workflows, subject to successful validation, procurement and regulatory readiness.

Independent clinicians and specialist clinics represent potential customers for assessment-support software and digital workflow services.

Healthcare organisations could access the platform through subscription or usage-based commercial models.

International expansion provides a further opportunity, subject to local regulatory approvals and market requirements.

Why OllieDX?

Our proposed differentiation is the integration of multiple behavioural and cognitive assessment methods into one AI-enabled platform.

Rather than relying on questionnaires alone, OllieDX aims to combine objective measurements with structured clinical information to support professional assessment.

Our technology strategy also incorporates responsible AI, explainability, data protection, cybersecurity, clinical safety monitoring and human oversight.

We are pursuing a regulatory approach aligned with applicable MHRA medical-device requirements and recognised AI governance and medical-device standards.

Investment priorities

We are seeking investment to support five priorities.

1. Complete development and integration of the multimodal AI assessment platform.

2. Undertake independent clinical evaluation, model validation, performance testing and bias assessment.

3. Progress MHRA medical-device classification, quality management and applicable regulatory requirements.

4. Establish pilot programmes and commercial partnerships with suitable healthcare providers.

5. Strengthen product engineering, cybersecurity, AI operations and commercial delivery capabilities.

Our ambition

Our long-term ambition is to build a trusted AI-enabled assessment infrastructure supporting clinicians, healthcare organisations and patients.

We aim to establish a commercially sustainable platform combining clinical assessment-support technology, digital workflows and scalable healthcare services.

Investment and partnership invitation

We welcome discussions with angel investors, healthtech venture capital funds, family offices, strategic healthcare investors and organisations interested in supporting the responsible deployment of AI in healthcare.

We are particularly interested in investors who bring healthcare market experience, clinical partnerships, regulatory expertise and commercial growth support.

OllieDX offers an opportunity to participate in developing a technology-led business addressing a recognised healthcare service challenge.

We invite interested investors and strategic partners to discuss our development roadmap, investment requirements, commercial model and proposed milestones.

Website: https://olliedx.co.uk